4th May, 2020 - Press notes
This is the first time that anyone has studied how brain alterations at a functional level in mice with Down syndrome respond to chronic treatment with a component of green tea that we know, from other studies, improves executive functions in adults with Down syndrome.
March 9th 2020 - Press release
Researchers at the Hospital del Mar Institute for Medical Research have led a study demonstrating how the relationship between two molecules plays a key role in the generation of these cells. The work has been published in The EMBO Journal.
February 14th 2020 - Press release
A joint study between Hospital del Mar, IDIBELL, the University of Helsinki and the Spanish National Research Council funded by La Marató de TV3 tries to analyze the effects of music therapy (musical learning) once patients have finished hospital rehabilitation and are in a chronic state of the disease. To do this, they designed a keyboard linked to a smart tablet that allows the participants of the study to do their exercises at home and learn gradually in an established manner. An earlier study of the same group shows that musical therapy, like other therapies, has similar effects in motor rehabilitation for patients who have suffered a stroke, having a strong impact in mood improvement and quality of life.
February 6th 2020 - Press notes
The company, founded today, is backed by IMIM and UPF and is developing products and services based on the DisGeNET platform, one of the tools on the genetics of diseases with most information in the world.
December 13th - Press release
Researchers led by Dr. Consol Serra have studied the exact, individualized cost of patients suffering from occupational diseases admitted to Hospital del Mar.
29th October, 2019 - Press release
A study by the Hospital del Mar Medical Research Institute (IMIM), Hospital del Mar, ISGlobal, and Brown University, in the United States, has revealed that xposure to high levels of traffic noise increases the risk of suffering a more serious ischaemic stroke by 30%. Conversely, proximity to green areas has a beneficial effect and reduces the risk of a more serious stroke by 25%. The work, published in the journal Environmental Research, analysed data from nearly 3,000 patients treated at Hospital del Mar.
23rd August, 2019 - Press notes
Preliminary results from a clinical trial led by the Hospital del Mar Medical Research Institute and Hospital del Mar show a good response to the drug in patients with metastatic tumours that did not respond to the usual treatment. It involves an inhibitor of a dual protein, mTORC1/2, which is key in tumour growth. The researchers had already demonstrated its effectiveness in in vitro and mouse models, in a study published in the journal Molecular Cancer Research.
10 July, 2019 - Press notes
Researchers from the Hospital del Mar Medical Research Institute have been able to prevent the growth of tumours and eliminate them using a treatment that combines chemotherapy with a protein inhibitor to prevent the repair of damaged DNA in cancer cells. The feasibility of this approach has been tested in mice, studying the evolution of metastatic colon tumours from human patients. The use of this drug combination will now be studied in human patients. The research has been published in the journal Molecular Cell.
28 June 2019 - Press notes
Study published in Cancer Immunology Research
Ageing of NK lymphocytes (Natural killer cells) in HER2-positive breast cancer patients can predict the success or failure of targeted treatments. A blood sample is sufficient for detecting this possible resistance biomarker that, if validated, will allow the therapy to be adapted when the disease is diagnosed. This is the first study to identify NK lymphocyte ageing as a parameter that may condition their anti-tumour potential.20 May, 2019 - Press release
Barcelona Supercomputing Center, UPC and Institut Hospital del Mar d'Investigacions Mèdiques organize the first Advances in Computational Biology conference will bring together researchers working on systems biology, omics technologies, artificial intelligence and high-performance computing (HPC) with applications to biology from both the public and the private sectors. The conference will be held November 28-29 in La Pedrera (Barcelona).
Parc Salut Mar
Passeig Marítim 25-29 Barcelona 08003
See location on Google maps
Phone: 93 248 30 00 · Fax: 93 248 32 54
Information request
© 2006 - 2025 Hospital del Mar · Legal notice and Privacy Police | Cookie Policy | Accessibility
